Ewa Janczewska
Myslowice, ZP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Corrigendum to "Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study" [JHEP Reports 2025 7(10) 101516].
Journal: JHEP reports : innovation in hepatology
Published: December 30, 2025
Risk of hepatocellular carcinoma recurrence in liver transplant recipients following treatment of hepatitis C with direct-acting antivirals.
Journal: Polish archives of internal medicine
Published: October 07, 2025
Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation.
Journal: Journal of clinical medicine
Published: October 06, 2025
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.
Journal: World journal of hepatology
Published: February 10, 2025
Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study.
Journal: JHEP reports : innovation in hepatology
Published: January 12, 2025
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.
Journal: Scientific reports
Published: December 23, 2024
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.
Journal: Journal of clinical medicine
Published: October 27, 2024
Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B.
Journal: Hepatology communications
Published: October 02, 2024
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Journal: Expert review of anti-infective therapy
Published: May 09, 2024
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.
Journal: Pharmacological reports : PR
Published: May 03, 2024
Last Updated: 09/26/2026